Get started
Author

Matthew Dankner

Observed names: Dankner, Matthew, M Dankner, M. Dankner
ORCID: 0000-0003-4869-5895
Observed ORCID: 0000-0003-4869-5895
OpenAlex ID: A5087616570
Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations
2018 · Matthew Dankner, April A. N. Rose, et al. · Oncogene · 552
Single-cell spatial immune landscapes of primary and metastatic brain tumours
2023 · Elham Karimi, Miranda W. Yu, et al. · Nature · 406
Neoadjuvant Chemoimmunotherapy for NSCLC
2024 · Mark Sorin, Connor Prosty, et al. · JAMA Oncology · 239
PDF
Spatially mapping the immune landscape of melanoma using imaging mass cytometry
2022 · Dan Moldoveanu, LeeAnn Ramsay, et al. · Science Immunology · 127
CEACAM1 as a Multi-Purpose Target for Cancer Immunotherapy
2017 · Matthew Dankner, Scott D Gray-Owen, et al. · OncoImmunology · 117
PDF
Dual MAPK Inhibition Is an Effective Therapeutic Strategy for a Subset of Class II BRAF Mutant Melanomas
2018 · Matthew Dankner, Mathieu Lajoie, et al. · Clinical Cancer Research · 75
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer
2021 · Stephanie P. Totten, Young Kyuen Im, et al. · Nature Communications · 60
PDF
Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors
2020 · Paul Savage, Alain Pacis, et al. · Communications Biology · 53
PDF
Clinical Activity of Mitogen-Activated Protein Kinase–Targeted Therapies in Patients With Non–V600 BRAF-Mutant Tumors
2022 · Matthew Dankner, Yifan Wang, et al. · JCO Precision Oncology · 48
The role of CRAF in cancer progression: from molecular mechanisms to precision therapies
2024 · Melody Riaud, Jennifer Maxwell, et al. · Nature reviews. Cancer · 40
Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastases
2021 · Matthew Dankner, Maxime Caron, et al. · Neuro-Oncology · 37
Non-small-cell lung cancer: how to manage BRAF-mutated disease
2023 · Giorgia Guaitoli, Lodovica Zullo, et al. · Drugs in Context · 34
PDF
Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes
2024 · Matthew Dankner, Sarah M Maritan, et al. · Neuro-Oncology · 33
The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers
2021 · Matthew Dankner, Stephanie Lam, et al. · Cancers · 32
PDF
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases
2023 · Anna-Maria Lazaratos, Sarah M. Maritan, et al. · The Breast · 28
PDF
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy
2022 · Shivshankari Rajkumar, Diana Berry, et al. · Cell Reports · 25
PDF
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision Oncology
2018 · Matthew Dankner · JCO Precision Oncology · 22
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
2018 · Cynthia Bernier, Ahmed Soliman, et al. · Anti-Cancer Drugs · 22
Radiomics as an emerging tool in the management of brain metastases
2022 · Alexander Nowakowski, Zubin Lahijanian, et al. · Neuro-Oncology Advances · 19
PDF
p66ShcA functions as a contextual promoter of breast cancer metastasis
2020 · Kyle Lewis, Alex Kiepas, et al. · Breast Cancer Research · 15
PDF
The Clinical, Genomic, and Transcriptomic Landscape of BRAF Mutant Cancers
2024 · Suzanne Kazandjian, Emmanuelle Rousselle, et al. · Cancers · 13
PDF
Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis
2024 · David J.H. Bian, Anna-Maria Lazaratos, et al. · Heliyon · 12
CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis
2019 · Matthew Dankner, Véronique Ouellet, et al. · American Journal Of Pathology · 11
PDF
The Real-World Clinical Outcomes of Heavily Pretreated HER2+ and HER2-Low Metastatic Breast Cancer Patients Treated with Trastuzumab Deruxtecan at a Single Centre
2024 · Anna-Maria Lazaratos, Matthew Dankner, et al. · Current Oncology · 9
PDF
Cerebral spinal fluid analyses and therapeutic implications for leptomeningeal metastatic disease
2024 · Jie Wei Zhu, Megan Shum, et al. · Journal of Neuro-Oncology · 9
Works count: 101
Citation count: 2,099
H-index: 19
I10-index: 23
Year
Topic
Type